Brief: Hofseth Biocare Signs Letter Of Intent With Garden Of Life In US

Hofseth Biocare ASA

24/06/2019 07:32

June 24 (Reuters) - Hofseth Biocare ASA  HOFBC.OL :
    * REG-HOFSETH BIOCARE ASA: SIGNED LETTER OF INTENT WITH
GARDEN OF
LIFE® FOR EXCLUSIVE USE OF COLLAGO® AND PROGO® IN THE US MARKET
    * AS SOON AS FINAL ORGANOLEPTIC TESTS ARE DONE, PARTIES
ENVISAGE
ENTERING INTO A LONG-TERM AGREEMENT
    * PARTIES AIM TO FINALIZE TESTING IN 2019 AND LAUNCH
PRODUCTS IN
US MARKET EARLY IN 2020
    * PRODUCTS WILL BE DISTRIBUTED BY HBC'S PARTNER IN US,
CHICAGO-BASED HOFSETH NORTH AMERICA, LLC, WHICH NEGOTIATED THIS
AGREEMENT
    * HOFSETH BIOCARE - INTENTION IS TO DEVELOP CLOSE
COLLABORATION ON
CULTIVATING AND DEVELOPING WORLD MARKET FOR HBC'S PRODUCTS

Source text for Eikon:  ID:nGNE858H96 
Further company coverage:  HOFBC.OL 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))